TABLE OF CONTENTS

Welcoming letter from William T. McGivney, PhD, NCCN’s Chief Executive Officer
Multiple myeloma: recent advances in induction therapy and transplant options
The changing role of chemotherapy and transplantation in chronic myelogenous leukemia
Management options for chronic lymphocytic leukemia
Myelodysplastic syndromes: treatment by risk group and the value of supportive care
Strategies for improving outcomes in adult acute myelogenous leukemia
Focus of new treatment directions in leukemia

Copyright © 2006 by the National Comprehensive Cancer Network. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the NCCN.

The treatment algorithms discussed in the Highlights of the 1st Annual NCCN Hematologic Malignancies Congress (NCCN Highlights) are a statement of consensus of the panel members regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these guidelines is expected to use independent medical judgment in the context of individual circumstances to determine any patient’s care or treatment. The reports of presentations included herein are based on the work of the presenters listed. Furthermore, the reader is advised that, except where specifically stated, all of the ideas and opinions expressed in the NCCN Highlights are the presenters’ own and do not necessarily reflect those of the NCCN, the member organizations, the editor, or the publisher. Publication of an advertisement or other product mention in the NCCN Highlights should not be construed as an endorsement of the product or manufacturer’s claims.

The information contained in the NCCN Highlights is presented for the purpose of educating our readership on cancer treatment and management. The information should not be relied on as complete or accurate, nor should it be relied on to suggest a course of treatment for a particular individual. It should not be used in place of a visit, call, consultation, or the advice of a licensed physician or other qualified health care provider. Patients with health care-related questions or concerns are advised to contact a physician or other qualified health care provider promptly.

Although every attempt has been made to verify that information presented within is complete and accurate, the information is provided “AS IS” without warranty, express or implied. The NCCN hereby excludes all implied warranties of merchantability and fitness for a particular use or purpose with respect to the information. Furthermore, the NCCN makes no warranty as to the reliability, accuracy, timeliness, usefulness, adequacy, completeness, or suitability of the information.

Discussions, views, opinions, and recommendations as to medical procedures, products, choice of drugs, and drug dosages are the responsibility of the authors or advertisers. No responsibility is assumed by the Publisher, Editor, or Editorial Board for any injury and/or damage to persons or property as a matter of product liability, negligence, or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should be made.